These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38565059)

  • 1. Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.
    Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D
    Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
    Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
    Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells.
    Zheng P; Xia Y; Shen X; Lu H; Chen Y; Xu C; Qiu C; Zhang Y; Zou P; Cui R; Huang X
    Int J Biol Sci; 2024; 20(1):249-264. PubMed ID: 38164168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
    Du Y; Zhang H; Lu J; Holmgren A
    J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.
    Dai B; Yoo SY; Bartholomeusz G; Graham RA; Majidi M; Yan S; Meng J; Ji L; Coombes K; Minna JD; Fang B; Roth JA
    Cancer Res; 2013 Sep; 73(17):5532-43. PubMed ID: 23824739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production.
    Wang R; Zhong L; Wang T; Sun T; Yang J; Liu X; Wu Y; Guo Q; Gao Y; Zhao K
    Neoplasia; 2024 Jul; 53():101004. PubMed ID: 38733769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt.
    Li Y; Yang DQ
    Mol Cancer Ther; 2010 Jan; 9(1):113-25. PubMed ID: 20053781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.
    Zhang T; Zheng P; Shen X; Shao R; Wang B; Shen H; Zhang J; Xia Y; Zou P
    Free Radic Biol Med; 2019 Sep; 141():93-102. PubMed ID: 31176737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
    Harris BRE; Zhang Y; Tao J; Shen R; Zhao X; Cleary MP; Wang T; Yang DQ
    FASEB J; 2021 Apr; 35(4):e21264. PubMed ID: 33715230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM inhibition enhances Auranofin-induced oxidative stress and cell death in lung cell lines.
    Ehrenfeld V; Heusel JR; Fulda S; van Wijk SJL
    PLoS One; 2020; 15(12):e0244060. PubMed ID: 33338048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA.
    Hedström E; Eriksson S; Zawacka-Pankau J; Arnér ES; Selivanova G
    Cell Cycle; 2009 Nov; 8(21):3584-91. PubMed ID: 19838062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.
    Zhuge W; Chen R; Vladimir K; Dong X; Zia K; Sun X; Dai X; Bao M; Shen X; Liang G
    Cancer Lett; 2018 Jan; 412():46-58. PubMed ID: 29037867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.
    Oh BM; Lee SJ; Cho HJ; Park YS; Kim JT; Yoon SR; Lee SC; Lim JS; Kim BY; Choe YK; Lee HG
    Cell Death Dis; 2017 Mar; 8(3):e2682. PubMed ID: 28300829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening.
    Ni Y; Luo Z; Lv Y; Ma S; Luo C; Du D
    Biochem Biophys Res Commun; 2023 Apr; 650():117-122. PubMed ID: 36780763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.
    Liu C; Liu Z; Li M; Li X; Wong YS; Ngai SM; Zheng W; Zhang Y; Chen T
    PLoS One; 2013; 8(1):e53945. PubMed ID: 23342042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
    Golding SE; Rosenberg E; Valerie N; Hussaini I; Frigerio M; Cockcroft XF; Chong WY; Hummersone M; Rigoreau L; Menear KA; O'Connor MJ; Povirk LF; van Meter T; Valerie K
    Mol Cancer Ther; 2009 Oct; 8(10):2894-902. PubMed ID: 19808981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
    Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation.
    Chen W; Zou P; Zhao Z; Weng Q; Chen X; Ying S; Ye Q; Wang Z; Ji J; Liang G
    Oncotarget; 2016 Mar; 7(13):16593-609. PubMed ID: 26919094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
    He W; Cao P; Xia Y; Hong L; Zhang T; Shen X; Zheng P; Shen H; Zhao Y; Zou P
    Free Radic Res; 2019 Jan; 53(1):104-114. PubMed ID: 30668191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
    Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
    Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.